USSTOCK.TODAY
Pre-Market
Log in Sign up

Sangamo Therapeutics Inc(SGMO) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

Halted
Trading Halted Since 2026-06-04: Trading has been halted. It may resume, and prices shown reflect the last trading day.
SGMO
SGMO
Halted
Sangamo Therapeutics Inc
$0.18
+0.00 +0.00%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -0.44Insider Own ⓘ 1.02%Shs Outstand ⓘ 414.3MPerf Week ⓘ 48.99%
Market Cap ⓘ 0.07BForward P/E ⓘ -EPS next Y ⓘ 71.05%Insider Trans ⓘ -8.96%Shs Float ⓘ 410.1MPerf Month ⓘ -30.27%
Enterprise Value ⓘ 0.08BPEG ⓘ -EPS next Q ⓘ 0.01Inst Own ⓘ 14.96%Short Float ⓘ 10.46%Perf Quarter ⓘ -49.76%
Income ⓘ -0.12BP/S ⓘ 1.86EPS this Y ⓘ 56.82%Inst Trans ⓘ -0.24%Short Ratio ⓘ 4.73Perf Half Y ⓘ -68.38%
Sales ⓘ 0.04BP/B ⓘ -EPS next 5Y ⓘ -ROA ⓘ -148.26%Short Interest ⓘ 42.88MPerf YTD ⓘ -57.71%
Book/sh ⓘ -0.04P/C ⓘ 3.51EPS past 3/5Y ⓘ 29.38% 13.38%ROE ⓘ -2891.84%52W High ⓘ -76.81% ($0.77)Perf Year ⓘ -75.61%
Cash/sh ⓘ 0.05P/FCF ⓘ -Sales past 3/5Y ⓘ -29.17% -19.66%ROIC ⓘ -1135.63%52W Low ⓘ 53.77% ($0.12)Perf 3Y ⓘ -86.94%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ 14.22%Gross Margin ⓘ 80.78%Volatility(W/M) ⓘ 27.02% 17.62%Perf 5Y ⓘ -98.44%
Dividend TTM ⓘ -EV/Sales ⓘ 2.01Sales Y/Y TTM ⓘ -31.57%Oper. Margin ⓘ -273.07%ATR (14) ⓘ 0.04Perf 10Y ⓘ -96.83%
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 0.84EPS Q/Q ⓘ 0.45%Profit Margin ⓘ -310.81%RSI (14) ⓘ 38.2Recom ⓘ 2
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 0.84Sales Q/Q ⓘ 88.43%SMA20 ⓘ -21.93% ($0.23)Beta ⓘ 1.07Target Price ⓘ $3.75
Payout ⓘ -Debt/Eq ⓘ -Earnings ⓘ 2026/3/30SMA50 ⓘ -43.1% ($0.32)Rel Volume ⓘ 0Prev Close ⓘ $0.18
Employees ⓘ 142LT Debt/Eq ⓘ -EPS/Sales Surpr. ⓘ -1322.22% -64.63%SMA200 ⓘ -61.39% ($0.47)Avg Volume(3M) ⓘ 9.06MPrice ⓘ $0.18
IPO ⓘ 2000/4/6Option/Short ⓘ Yes/YesTrades ⓘ 0Volume ⓘ -Change ⓘ -
Company
SGMO SGMOSangamo Therapeutics Inc | NASD | Biotechnology Deep dive

🧬 A leading U.S. genome editing company developing therapeutics for hereditary and neurological diseases based on Zinc Finger protein technology. The company is accelerating the commercialization of a gene therapy for Fabry disease and leading innovation in next-generation neurological disease treatment technologies.

Quote

Over the past 1 year, on the lower side

77% below its 1-year high.

Now $0.18
52w low$0.1252w high$0.77
52W Range9%
Volume ⓘ 0

Traded less than usual. That is 0% of its average volume.

C
Overall · average, with some caution
We judged 6 of the 8 questions below. 2 rate excellent and 2 need caution.
No data for earnings, dividends, or not applicable.
ETFs holding this stock 5 ETFs

Multiple ETFs hold this stock, but only a sliver

Buying this ETF gives you exposure to this stock as well.

Peer comparison Biotechnology

It ranks #374 of 599 in the industry

Based on market cap of $74M.

FAQ

FAQ

What kind of company is SGMO?

SGMO belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of SGMO?

The market cap of SGMO is approximately $74M, ranking 4,732 within its sector.

What is the 52-week high and low for SGMO?

SGMO has recorded a 52-week high of $0.77 and a low of $0.12.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels